TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | -1 | -7 | -2 | 1 | 25 | 3 |
| P | %wins | 100 | 50 | 0 | 50 | 50 | 100 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/10 13:01 | 5/14/10 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Larson Christine R | NV | O | VP,CFO | P | 29 | 5.71 | 30 | 5 | 13 | 44 | D | 34 | 20 | -7 | -7 | -10 | -10 | -3 | -1 | 2 | -4 | -3 | -10 | 3 | 25 |
5/3/10 15:11 | 4/30/10 | PDLI | Pdl Biopharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Larson Christine R | NV | O | VP,CFO | P | 62 | 6.18 | 26 | 10 | 35 | 39 | D | 36 | 15 | -2 | -2 | -12 | -8 | -11 | -9 | 3 | 2 | -10 | 7 | -2 | 24 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |